Item 16. FORM 10-K SUMMARY
4K characters. Original on sec.gov · Markdown
Item 16. FORM 10-K SUMMARY
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMERISOURCEBERGEN CORPORATION | ||||
| Date: November 19, 2019 | By: | /s/ STEVEN H. COLLIS Steven H. Collis Chairman, President and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below as of November 19, 2019 by the following persons on behalf of the Registrant and in the capacities indicated.
| Signature | Title | |
| /s/ STEVEN H. COLLIS___________________________ Steven H. Collis | Chairman, President and Chief Executive Officer (Principal Executive Officer) | |
| /s/ JAMES F. CLEARY____________________________ James F. Cleary | Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |
| /s/ LAZARUS KRIKORIAN________________________ Lazarus Krikorian | Senior Vice President and Chief Accounting Officer (Principal Accounting Officer) | |
| /s/ _____________________________________________ Ornella Barra | Director | |
| /s/ D. MARK DURCAN____________________________ D. Mark Durcan | Director | |
| /s/ RICHARD W. GOCHNAUER____________________ Richard W. Gochnauer | Director | |
| /s/ LON R. GREENBERG__________________________ Lon R. Greenberg | Director |
| Signature | Title | |
| /s/ JANE E. HENNEY, M.D.________________________ Jane E. Henney, M.D. | Lead Independent Director | |
| /s/ KATHLEEN W. HYLE__________________________ Kathleen W. Hyle | Director | |
| /s/ MICHAEL J. LONG____________________________ Michael J. Long | Director | |
| /s/ HENRY W. MCGEE____________________________ Henry W. McGee | Director |
AMERISOURCEBERGEN CORPORATION AND SUBSIDIARIES
SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
| (In thousands) | Balance at Beginning of Period | Charged to Costs and Expenses (1) | Deductions- Describe (2) | Balance at End of Period (3) | ||||||||||||
| Year Ended September 30, 2019 | ||||||||||||||||
| Allowances for returns and doubtful accounts | $ | 1,049,901 | $ | 3,720,642 | $ | (3,546,656 | ) | $ | 1,223,887 | |||||||
| Year Ended September 30, 2018 | ||||||||||||||||
| Allowances for returns and doubtful accounts | $ | 1,068,251 | $ | 3,397,562 | $ | (3,415,912 | ) | $ | 1,049,901 | |||||||
| Year Ended September 30, 2017 | ||||||||||||||||
| Allowances for returns and doubtful accounts | $ | 926,034 | $ | 3,157,960 | $ | (3,015,743 | ) | $ | 1,068,251 |
| (1) | Represents the provision for returns and doubtful accounts. |
| (2) | Represents reductions to the returns allowance and accounts receivable written off during year, net of recoveries. |
| (3) | Includes an allowance for doubtful accounts for long-term accounts receivable within Other Assets on the Consolidated Balance Sheets of $981 thousand, $13,568 thousand and $17,890 thousand as of September 30, 2019, 2018, and 2017, respectively. |
Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details